Revance Therapeutics Inc (RVNC)

[mouton29]

The_presentation_session_ought_to_be_titled, “Dispelling the Double-Dose Canard.”

Agreed, but the jury’s out so far as I’m concerned, it could turn into “promoting the double dose canard”. You’d think investigators for Revance would understand the point but (i) they also promote/investigate for competitors and (ii) it’s rare to see a publication correctly stating the comparative active ingredient amounts.